Furthermore, PB-CRD offered superior benefits in reducing total body fat and improving uric acid metabolism, while improving insulin sensitivity and liver function in adults with obesity.<h4>Clinical trial registration</h4>Identifier ChiCTR1800015156. This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.